The plaques celebrating the incredible team involved in making this huge scientific breakthrough, have been installed at our laboratories in Chelsea and Sutton.
The BRCA2 cancer gene
Mutations, or faults, in the BRCA2 gene can cause breast, ovarian, prostate and pancreatic cancer. Discovering the gene was a major scientific breakthrough which led to genetic tests for cancer and underpinned the development of new treatments, saving thousands of lives.
Many people think that breakthroughs like this happen as a result of one or two talented individuals’ work – but often it takes a large team of exceptional researchers to collectively reach such a milestone.
These commemorative plaques put a spotlight on our teams’ discoveries, and the impact they are making on cancer treatments and cancer patients’ lives, worldwide.
Caroline was diagnosed with triple negative breast cancer in 2019. Just after finishing her treatment, she found out she had a mutation in her BRCA2 gene. Caroline says:
"I didn't know anything about the BRCA2 mutation before I went through genetic testing. I was devastated to learn I was a carrier, but ultimately knowledge is power – the news does affect the rest of your life, but it also gives you options to manage your risk.
“It’s very reassuring to know that cancer research is leading to more advances in diagnosis and treatment, and I’m so thankful that by the time my children are grown up, they will hopefully have more options.”
Caroline Wheeldon from Barnsley, pictured with her daughter.
We can’t do this alone
As well as being a world-leading cancer research institute, we are a charity. We rely on the generosity of supporters and donors like you, to sustain our work into the future.
Help us make the next big discovery. Help us make the discoveries that defeat cancer.
Make a donation
Find out more about our major discoveries, including the BRCA2 breast cancer gene.